Sales of Scoring Balloon Catheter for Dialysis is Expected to Gain Steadfast Traction, Procuring an Annual Growth of more than US$ 200 Mn | Fact.MR

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

The growing prevalence of peripheral vascular and coronary artery diseases has fuelled demand for scoring balloon catheter devices in the healthcare sector. Moreover, increasing demand for medical devices equipped with enhanced technology is projected to impact the global market growth of scoring balloon catheter positively. According to a recently published report, the global scoring balloon catheter market will reflect sluggish CAGR growth over the forecast period, 2017 – 2022.

For detailed insights on enhancing your product footprint, request a sample here

Factors Propelling Global Market Growth

The increasing prevalence of coronary artery diseases has led to an upsurge in demand for scoring balloon catheter devices in the healthcare sector. Healthcare manufacturers prefer scoring balloon catheter devices over conventional devices for the treatment of coronary artery diseases attributed to limitations such as uncontrolled dissections including bailout stenting and insufficient luminal expansion. Moreover, healthcare professionals prefer using scoring balloon catheter devices over conventional catheter devices for the treatment of peripheral vascular diseases. The fibrocalcific lesion is resistant to dilation through conventional balloon catheter devices attributed to inadequate luminal expansion. Due to these factors, manufacturers are adopting scoring technology for the production of scoring balloon catheter devices in the healthcare sector. These factors are likely to contribute towards the global market growth of scoring balloon catheter positively.

On the other hand, growing risks regarding artery collapse during the catheterization treatment are projected to influence demand for scoring balloon catheter devices negatively. Moreover, increasing risks of infection due to the treatment of catheterization is projected to pose significant challenges for scoring balloon catheter devices in the global market by 2022 – end. These factors are expected to inhibit the global market growth of scoring balloon catheter devices during the projected period.

For comprehensive insights on this market adoption, ask an analyst here

Market Segmentation 

Global Scoring Balloon Catheter Market Analysis and Forecast By Indication

  • Coronary Artery Disease Scoring Balloon Catheter
  • Peripheral Vascular Disease Scoring Balloon Catheter

Global Scoring Balloon Catheter Market Analysis and Forecast By End User 

  • Hospitals Scoring Balloon Catheter
  • Ambulatory Surgical Centers Scoring Balloon Catheter
  • Cardiac Catheterization Laboratories Scoring Balloon Catheter

Global Scoring Balloon Catheter Market Analysis and Forecast By Raw Material 

  • Polyurethane Scoring Balloon Catheter
  • Nylon to Represent a Leading Market

Global Scoring Balloon Catheter Market Analysis and Forecast By Region

  • North America
  • Europe
  • Asia-Pacific (APAC)
  • Japan
  • Latin America (LATAM)
  • MENA

Cardiac catheterization laboratories are projected to register a relatively high CAGR among other end users in the global market of scoring balloon catheter through 2022. In revenue terms, hospitals will witness relatively high growth in the global market by 2022–end. Hospitals in Europe are projected to generate significant revenue globally throughout 2022.

In terms of disease indications, coronary artery disease is projected to represent a relatively high growth in revenue terms in the global market of scoring balloon catheter devices. This segment will witness around US$ 40 Mn in the global market in 2017. The peripheral vascular disease segment is projected to register significant growth after the coronary artery disease segment.

Full Access of this Exclusive Report is Available at-

Nylon among various raw materials is projected to register a relatively high growth in revenue terms throughout 2022. This segment will represent US$ 30 Mn by the end of 2017. Among other regions, North America will witness a major market for the nylon segment globally. Polyurethane is projected to reflect a relatively high CAGR in the global market by 2022 – end.

Market Players

Key players in the global market of scoring balloon catheter are

  • B. Braun Melsungen AG
  • Medtronic Plc
  • Tokai Medical Products Inc.
  • Terumo Corporation
  • Boston Scientific Corporation
  • Jotech GmbH
  • MicroPort Scientific Corporation
  • Hexacath
  • Meril Life Sciences Pvt Ltd
  • Cordis Corporation
  • Abbott Laboratories

Explore Fact.MR’s Coverage on the Healthcare Domain

Implantable Pump Catheter Market: A recent study by Fact.MR on the Implantable Pump Catheter Market offers a 10-year forecast analysis for the period 2021 to 2031. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Coronary Microcatheters Market: Fact.MR’s extensive coverage on the Coronary Microcatheters Market offers in-depth insights into the prominent growth dynamics that are likely to aid the expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Chronic Total Occlusion Catheter Market: The Chronic Total Occlusion Catheter Market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities, and trends expected to shape future expansion outlook. The report provides a comprehensive assessment of the prominent segments and geographies which are likely to benefit market players in the forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Research Insight:
Content Source:




Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles